Investor Alert

Company Close Updates

May 17, 2022, 4:33 p.m. EDT

Johnson & Johnson stock rises Tuesday, still underperforms market

MarketWatch Automation

Shares of Johnson & Johnson (NYS:JNJ) inched 0.42% higher to $178.82 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index (S&P:SPX) rising 2.02% to 4,088.85 and the Dow Jones Industrial Average (DOW:DJIA) rising 1.34% to 32,654.59. This was the stock's second consecutive day of gains. Johnson & Johnson closed $7.87 short of its 52-week high ($186.69), which the company achieved on April 25th.

The stock underperformed when compared to some of its competitors Tuesday, as Roche Holding AG Part. Cert. (OTC:RHHVF) rose 2.26% to $322.62, Merck & Co. Inc. (NYS:MRK) rose 0.74% to $93.00, and Pfizer Inc. (NYS:PFE) rose 1.32% to $51.34. Trading volume (5.7 M) remained 2.0 million below its 50-day average volume of 7.8 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Link to MarketWatch's Slice.